How Visitor Management Systems are Empowering Pharmaceutical Organizations

See how the world's largest pharma companies view visitor management, and why most still don't have one, in one quick infographic.

We asked IT and security leaders at some of the world's largest pharmaceutical companies how visitor management helps their organizations. 66% consider it critical to their security and operations, yet fewer than one in four have one in place. This one-page infographic shows why, and how priorities differ between smaller and larger companies.

Visitor management in pharma, at a glance

Get the full infographic as a PDF to read later or share with your team.

Get the infographic

‍

What's inside

Why pharma companies adopt cloud-based visitor management
Visitor check-in times across the industry
How priorities change with company size
The perceptions that hold companies back before they implement

We asked IT and Security Leaders at some of the largest Pharmaceutical companies in the world how does visitor management empower your organization? Here’s what they told us.

Why do Pharmaceutical companies adopt a cloud-based VMS?

Improve brand perception
Provide standardization
Enhance the visitor experience
Improve efficiency
Ensure compliance
Create a safer environment
We do not have/want a VMS

Processing time (seconds)

Most visitors are processed in 30–60 seconds, followed by 61–90 seconds and 91–120 seconds. Under 30 seconds, 121–150 seconds and “Unsure” are the smallest shares.

Size Matters

Standardization is a priority for

36% of Pharmaceutical companies with a turnover of below $100 million.
75% of Pharmaceutical companies with a turnover of $500 million or more.

Enhancing the visitor experience was important for

53% of Pharmaceutical companies with a turnover of below $100 million.
25% of Pharmaceutical companies with a turnover of $500 million or more.